A review of nucleic acid aptamer-functionalized metal-organic frameworks for cancer biomarker detection
Source abstract
Abstract
Timely detection of cancer is an important step towards better cure rates, and patient prognosis, and the sensitive detection of biomarkers is a significant milestone in this direction. Biosensing uses of metal-organic frameworks (MOFs) due to the high specific surface area, tunable pore size, and excellent functionalization capability have unique benefits. Through the combination of high-affinity nucleic acid aptamers and MOFs, the resulting sensors could have a better sensitivity and sensing performance. This review is a summary of the research development in the last five years on aptamer-MOF composite systems in detecting cancer biomarkers. Particular emphasis is placed on immobilization strategies, signal transduction mechanisms, and the development of electrochemical、optical、photoelectrochemical、 electrochemiluminescent and other emerging sensing platforms, as well as their use in the detection of biomarkers, including ATP、CEA、CA15-3 and ctDNA. Lastly, the performance, constraints, and prospects of aptamer-MOF biosensors are addressed, including aptamer-MOF sensor sensitivity, aptamer-MOF sensor selectivity, aptamer-MOF sensor reproducibility, and aptamer-MOF sensor translatability.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Metal complexes synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Recent advances and emerging trends in cancer biomarker detection technologies10.1021/acs.iecr.2c04097 ↗
2. Biomarkers in cancer detection, diagnosis, and prognosis10.3390/s24010037 ↗
3. Cancer biomarkers and precision oncology: a review of recent trends and innovations10.1177/11795549241298541 ↗
4. Technologies for frugal and sensitive point-of-care immunoassays10.1146/annurev-anchem-061020-123817 ↗
5. Lateral flow assay: a summary of recent progress for improving assay performance10.3390/bios13090837 ↗
6. Recent advances in mass spectrometry based clinical proteomics: applications to cancer research10.1186/s12014-020-09283-w ↗
7. Recent advances on the metal-organic frameworks-based biosensing methods for cancer biomarkers detection10.1080/10408347.2022.2111197 ↗
8. Biosensor technologies in cancer: tools for early detection and prognostic monitoring10.1186/s40364-025-00884-x ↗
9. Chemical Sensors and Biosensors Based on Metal–Organic Frameworks (MOFs)10.3390/chemosensors13020072 ↗
10. Emerging biosensing platforms based on metal–organic frameworks (MOFs) for detection of exosomes as diagnostic cancer biomarkers: case study for the role of the MOFs10.1039/D4TB02465F ↗
11. Mitigating metal-organic framework (MOF) toxicity for biomedical applications10.1016/j.cej.2023.144400 ↗
12. Effects of exposure to different types of metal–organic framework nanoparticles on the gut microbiota and liver metabolism of adult zebrafish10.1021/acsnano.4c03451 ↗
13. Metal–organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications10.1039/D4RA04441J ↗
14. Nucleic acid aptamer-based biosensors: a review10.3390/biomedicines11123201 ↗
15. Aptamer and Oligonucleotide-Based Biosensors for Health Applications10.3390/bios15050277 ↗
16. Biomarkers for early cancer detection: A landscape view of recent advancements, spotlighting pancreatic and liver cancers10.1021/acsptsci.3c00346 ↗
17. Metal organic frameworks as advanced functional materials for aptasensor design10.1016/j.saa.2022.121251 ↗
18. A target responsive metal organic framework derived bimetallic Apta-Switch for reagentless molecular recognition10.1021/acs.langmuir.4c03752 ↗
19. An all-in-one portable colorimetric detection platform for sensitive detection of bisphenol A based on target-mediated CeO₂@ZIF-8/Apt biocomposites10.1016/j.jcis.2023.10.055 ↗
20. Metal organic frame-upconverting nanoparticle assemblies for the FRET based sensor detection of bisphenol a in high-salt foods10.3389/fbioe.2020.626269 ↗
21. Surface functionalization of metal–organic framework nanoparticle for overcoming biological barrier in cancer therapy10.1039/D4QI00523F ↗
22. Aptamer-functionalized metal-organic frameworks (MOFs) for biosensing10.1016/j.bios.2020.112947 ↗
23. Aptamer-functionalized metal organic frameworks as an emerging nanoprobe in the food safety field: Promising development opportunities and translational challenges10.1016/j.trac.2022.116622 ↗
24. Aptamer-functionalized MOFs and AI-driven strategies for early cancer diagnosis and therapeutics10.1007/s10529-023-03454-z ↗
25. Application of metal-organic framework as redox probe in an electrochemical aptasensor for sensitive detection of MUC110.1016/j.bios.2019.111433 ↗
26. A metal–organic framework/DNA hybrid system as a novel fluorescent biosensor for mercury (II) ion detection10.1002/chem.201503335 ↗
27. Ultrasensitive aptamer-functionalized Cu-MOF fluorescent nanozyme as an optical biosensor for detection of C-reactive protein10.1016/j.ab.2022.114928 ↗
28. Electrochemical aptasensors based on hybrid metal-organic frameworks10.3390/s20236963 ↗
29. A novel fluorescence aptasensor based on PCN-223 as an efficient quencher for sensitive determination of prostate-specific antigen10.1007/s00604-023-05650-0 ↗
30. Insight into the sensing behavior of DNA probes based on MOF–nucleic acid interaction for bioanalysis10.1021/acs.analchem.3c00832 ↗
31. Characterisation of aptamer-anchored poly (EDMA-co-GMA) monolith for high throughput affinity binding10.1038/s41598-019-50862-1 ↗
32. Aptamer-functionalized iron-based metal–organic frameworks (MOFs) for synergistic cascade cancer chemotherapy and chemodynamic therapy10.3390/molecules27134247 ↗
33. Unleashing the potential of QCM: A comprehensive review of aptamer-based QCM sensing analysis10.1016/j.microc.2024.110344 ↗
34. Quartz crystal microbalance-based aptasensors for medical diagnosis10.3390/mi13091441 ↗
35. Influence of aptamer surface coverage on small target recognition: A SPR and QCM-D comparative study10.1021/acs.jpcc.9b00845 ↗
36. Electrochemical impedance spectroscopic sensing of methamphetamine by a specific aptamer
37. Selection of high affinity aptamer-ligand for dexamethasone and its electrochemical biosensor10.1038/s41598-019-42671-3 ↗
38. Dual-current signal high-sensitivity detection of telomerase using signal amplified DNA functionalized metal-organic frameworks in glass nanopipettes10.1016/j.snb.2023.134950 ↗
39. Highly sensitive glass nanopipette sensor using composite probes of DNA-functionalized metal–organic frameworks10.1021/acs.analchem.1c05571 ↗
40. ZIF-8 metal–organic framework electrochemical biosensor for the detection of protein–protein interaction10.1021/acs.chemmater.0c04201 ↗
41. Aptameric Metal–Organic Framework Nanobiosensor10.1021/acsanm.4c03305 ↗
42. An ultra-sensitive dual-signal ratiometric electrochemical aptasensor based on functionalized MOFs for detection of HER210.1016/j.bioelechem.2022.108272 ↗
43. Metal organic frameworks (MOFs)-based fluorescent CA125 analysis: A comparative study of the quenching effects of MIL-101, Cu-MOF, ZIF-8, UiO-6610.1016/j.jphotochem.2024.116098 ↗
44. Electrochemical aptasensor based on the engineered core-shell MOF nanostructures for the detection of tumor antigens10.1186/s12951-023-01884-5 ↗
45. An investigation into the intrinsic peroxidase-like activity of Fe-MOFs and Fe-MOFs/polymer composites10.1002/admt.202001048 ↗
46. Room temperature synthesis mediated porphyrinic nanoMOF enables benchmark electrochemical biosensing10.1002/smll.202301933 ↗
47. Metal–organic framework (MOF) hybridized gold nanoparticles as a bifunctional nanozyme for glucose sensing10.1039/D3SC02598E ↗
48. Stimuli-responsive new horizons for biomedical applications: metal–organic framework-based nanozymes10.1002/sstr.202400029 ↗
49. Recent progress and prospect of metal–organic framework-based nanozymes in biomedical application10.3390/nano14030244 ↗
50. Research progress of metal–organic framework nanozymes in bacterial sensing, detection, and treatment10.1039/D3MD00581J ↗
51. A brief review of aptamer-based biosensors in recent years10.3390/bios15020120 ↗
52. Recent advances in electrochemical MOF-based aptasensors for cancer biomarker detection: a review10.1016/j.microc.2024.110924 ↗
53. Electrochemical protein biosensors for disease marker detection: progress and opportunities10.1038/s41378-024-00700-w ↗
54. A comprehensive review of MOFs based on electrochemical biosensors as smart platforms in cancer biomarkers detection10.1016/j.microc.2024.112498 ↗
55. A comprehensive review of metal–organic framework: synthesis, characterization, and investigation of their application in electrochemical biosensors for biomedical analysis10.3390/s22062238 ↗
56. Electrochemical (bio) sensors for cancer therapy monitoring10.1016/j.electacta.2025.146929 ↗
57. High ATP production fuels cancer drug resistance and metastasis: implications for mitochondrial ATP depletion therapy10.3389/fonc.2021.740720 ↗
58. ATP and adenosine metabolism in cancer: exploitation for therapeutic gain10.1124/pharmrev.121.000528 ↗
59. Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy10.1016/j.cellsig.2024.111281 ↗
60. Direct, real-time detection of adenosine triphosphate release from astrocytes in three-dimensional culture using an integrated electrochemical aptamer-based sensor10.1021/acschemneuro.9b00033 ↗
61. Label-free electrochemical detection of ATP based on amino-functionalized metal-organic framework10.1038/s41598-017-06858-w ↗
62. Two-dimension (2D) Cu-MOFs/aptamer nanoprobe for in situ ATP imaging in living cells10.1007/s41664-021-00172-1 ↗
63. Electrochemiluminescent quenching of luminol–doped Zr–MOFs for ATP detection through scavenging ROS using gallic acid–capped Au nanoparticles10.1016/j.snb.2024.135900 ↗
64. A controlled release aptasensor utilizing AIE-active MOFs as high-efficiency ECL nanoprobe for the sensitive detection of adenosine triphosphate10.1021/acs.analchem.3c04794 ↗
65. Electrochemiluminescence and Fluorescence Dual-Mode Aptamer Sensor Based on AIEgens-Based Self-Luminous Flower-like MOF for the Detection of Acetamiprid10.1021/acs.analchem.5c01866 ↗
66. Dual Recognition and Highly Sensitive Detection of ATP by Aptamer-Bridged MOF Functionalized Glass Nanopipette10.1021/acs.analchem.5c07972 ↗
67. Carcinoembryonic antigen (CEA): origin, role in oncology, and concentrations in serum and peritoneal fluid10.3390/jcm14093189 ↗
68. Advances in carcinoembryonic antigen detection: a review of clinical applications and standardization10.1007/s00216-025-05772-9 ↗
69. Stable DNA aptamer–metal–organic framework as horseradish peroxidase mimic for ultra-sensitive detection of carcinoembryonic antigen in serum10.3390/gels7040181 ↗
70. Bimetallic organic framework Cu/UiO-66 mediated “fluorescence turn-on” method for ultrasensitive and rapid detection of carcinoembryonic antigen (CEA)10.1016/j.aca.2021.339000 ↗
71. Labeled free electrochemiluminescence aptamer platform based on one-step cathodic electrochemical growth of 2D/3D Ru-BTC-MOFs nanoparticles to detect carcinoembryonic antigen10.1016/j.snb.2023.134816 ↗
72. Aptamer-controlled peroxidase activity of platinum nanoparticles/Fe-MOF nanozyme for highly effective voltammetric detection of carcinoembryonic antigen10.1016/j.microc.2024.110609 ↗
73. Homogeneous electrochemical detection of carcinoembryonic antigen based on target-controlled catalytical reaction of platinum/UiO-66 MOFs nanozyme integrated with aptamer10.1016/j.elecom.2025.108025 ↗
74. Circulating biomarkers in breast cancer10.1016/j.clbc.2021.09.006 ↗
75. Prognostic impact of elevation of cancer antigen 15-3 (CA15-3) in patients with early breast cancer with normal serum CA15-3 level10.4048/jbc.2023.26.e17 ↗
76. Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@ Au core-shell like nanostructure10.1038/s41598-024-78836-y ↗
77. Dual-wavelength responsive photoelectrochemical aptasensor based on ionic liquid functionalized Zn-MOFs and noble metal nanoparticles for the simultaneous detection of multiple tumor markers10.1039/D1NR05782K ↗
78. A fluorescent biosensor based on prismatic hollow Metal-polydopamine frameworks and 6-carboxyfluorescein (FAM)-labeled protein aptamer for CA15-3 detection10.1016/j.snb.2020.129249 ↗
79. A photocurrent polarity switching photoelectrochemical aptasensor based on Er-MOF nanosheets and methylene blue for high-performance determination of CA15-3
80. Metal-organic framework-based aptamer sensors for early diagnosis of breast cancer10.1016/j.sbsr.2025.100855 ↗
81. Liquid biopsy in cancer: current status, challenges and future prospects10.1038/s41392-024-02021-w ↗
82. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology10.1038/s41698-025-00876-y ↗
83. Enhanced the Trans-Cleavage Activity of CRISPR-Cas12a Using Metal-Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA
84. Bioreaction-compatible bivariate lanthanide MOF sensor enables stimulus-multiresponsive platform for ctDNA on-site detection10.1021/acs.analchem.4c01207 ↗
85. Construction of a sandwich-type DNA biosensor based on functionalized MOF@ COF nanomaterials for the detection of NSCLC biomarker ctDNA10.1039/D5TB01135C ↗
86. Recent innovations and developments in MOF-based aptasensors10.1016/j.microc.2025.114954 ↗
87. Next-generation electrochemical aptasensors for thrombin detection: the rise of aptamer–MOF architectures10.1007/s00216-026-06383-8 ↗
88. Emerging electrochemical biosensors for lung cancer-associated protein biomarker and miRNA detection
89. Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer
90. A perspective on the potential use of aptamer-based field-effect transistor sensors as biosensors for ovarian cancer biomarkers CA125 and HE410.1016/j.talanta.2025.127954 ↗
91. Photoelectrochemical aptasensors for biosensing: A review10.3390/chemosensors13090344 ↗
92. Photoelectrochemical biosensing platforms for tumor marker detection10.1016/j.ccr.2022.214675 ↗
93. Recent advances in optical and photoelectrochemical nanobiosensor technology for cancer biomarker detection
94. A self-powered photoelectrochemical aptasensor based on target response and Ag-CdIn2S4 photosensitive material for ultrasensitive detection of prostate-specific antigen10.1016/j.microc.2024.111278 ↗
95. Highly sensitive photoelectrochemical detection of cancer biomarkers based on CdS/Ni-CAT-1 nanorod arrays Z-scheme heterojunction with spherical nucleic acids-templated copper nanoclusters as signal amplification10.1016/j.snb.2022.132786 ↗
96. Electrochemistry/photoelectrochemistry-based immunosensing and aptasensing of carcinoembryonic antigen10.3390/s21227742 ↗
97. Electrochemiluminescence biosensors for detection of cancer biomarkers in biofluids: Principles, opportunities, and challenges10.1016/j.nantod.2023.101874 ↗
98. Recent advances in metal–organic framework-based photoelectrochemical and electrochemiluminescence biosensors10.1039/D3AN00222E ↗
99. Innovative strategies in metal-organic frameworks for enhanced electrochemiluminescence biosensors10.1016/j.ccr.2024.216161 ↗
100. Fabrication of electrochemiluminescence aptasensor for PD-L1 detection based on luminescent CdS@Ce-MOF@Au10.1016/j.microc.2023.109005 ↗